Reversible ocular myasthenia gravis or mitochondrial myopathy from statins?

Lancet. 2003 Jan 4;361(9351):85-6. doi: 10.1016/s0140-6736(03)12152-6.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anticholesteremic Agents / adverse effects*
  • Humans
  • Mitochondrial Myopathies / chemically induced*
  • Mitochondrial Myopathies / diagnosis
  • Myasthenia Gravis / chemically induced*
  • Myasthenia Gravis / diagnosis

Substances

  • Anticholesteremic Agents